Seminars in Cancer Biology

Volume contents, Auhtor and Keywords
pp. I-X(10)

Commentary
pp. 415-418(4)
Author: Klein G.

Introduction: nasopharyngeal cancer
pp. 419-419(1)
Authors: Huang D.P.; Johnson P.J.

Epidemiology of nasopharyngeal carcinoma
pp. 421-429(9)
Authors: Yu M.C.; Yuan J-M.

Epstein–Barr virus in the pathogenesis of NPC
pp. 431-441(11)
Author: Raab-Traub N.

Familial nasopharyngeal carcinoma
pp. 443-450(8)
Authors: Zeng Y-X.; Jia W-H.

Genetic and epigenetic changes in nasopharyngeal carcinoma
pp. 451-462(12)
Authors: Lo K-W.; Huang D.P.

Nasopharyngeal carcinoma and the EBV-specific T cell response: prospects for immunotherapy
pp. 463-471(9)
Author: Lee S.P.

The significance of LMP1 expression in nasopharyngeal carcinoma
pp. 473-487(15)
Authors: Tsao S.W.; Tramoutanis G.; Dawson C.W.; Lo A.K.F.; Huang D.P.

Circulating EBV DNA as a tumor marker for nasopharyngeal carcinoma
pp. 489-496(8)
Authors: Allen Chan K.C.; Dennis Lo Y.M.

Treatment strategy and clinical experience
pp. 497-504(8)
Authors: Teo P.M.L.; Chan A.T.C.

Novel gene therapy approach for nasopharyngeal carcinoma
pp. 505-515(11)
Author: Liu F-F.